Nextremity Solutions, Inc. announced preliminarily results of a new market research analysis indicating that forefoot deformities, such as hammertoes, are an endemic problem in the United States affecting as many as 20% of Americans.
According to Andrew Park, Senior Manager, Orthopedics at iDATA Research, a global medical device and pharmaceutical market intelligence firm, commented, “People who suffer from forefoot deformities remain one of the largest untreated orthopedic patient populations our firm has ever measured.” He added, “Research estimates that the 550,000 US hammertoe surgeries in 2012 will grow to 648,000 by 2017. Our research also shows up to 60 million patients suffer from hammertoe deformities and the overwhelming majority has not been diagnosed or undergone surgical treatment.”
David C. Novicki, DPM, FACFAS, Clinical Assistant Professor of Orthopedics, Yale School of Medicine and past President of the American College of Foot and Ankle Surgeons, stated, “We are not surprised with vast number of hammertoe sufferers in the US. Due to demographics and lifestyle changes, we expect these numbers to continue to grow over the next decade. Many people are simply not aware that there are interventional as well as conservative approaches to managing this painful condition and we urge people with a foot deformity to seek a consultation from their physician.”
Severe hammertoes are debilitating, causing pain, loss of mobility as well as being unsightly. Piper Jaffray estimates (June 6, 2011 report) the hammertoe implant market will represent $500 million to $1 billion in the US alone. These estimates do not include the millions of hammertoe sufferers who have yet to seek medical attention. Ten to twenty percent of the general population in developed countries has the hammertoe deformity. The US forefoot surgery market, which includes hammertoe correction and bunionectomies, already represents over 1.2 million procedures annually.
Source: Nextremity Solutions, Inc.